Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ru

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Science (New York, N.Y.)|January 21, 1994
Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitorsP Y Lam, P K Jadhav, C J Eyermann, et al.
The Journal of Biological Chemistry|January 20, 2001
Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitroI E James, R W Marquis, S M Blake, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2001
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primateG B Stroup, M W Lark, D F Veber, et al.
Bone|May 9, 2002
A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized ratMichael W Lark, G B Stroup, I E James, et al.
Journal of Medicinal Chemistry|September 11, 1998
Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin KR W Marquis, D S Yamashita, Y Ru, et al.
Chemistry & Biology|November 18, 1998
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitorsJ D Rodgers, P Y Lam, B L Johnson, et al.
Bioorganic & Medicinal Chemistry|June 3, 1999
Potent dipeptidylketone inhibitors of the cysteine protease cathepsin KR W Marquis, Y Ru, D S Yamashita, et al.
Journal of Medicinal Chemistry|March 23, 2001
Cyclic ketone inhibitors of the cysteine protease cathepsin KR W Marquis, Y Ru, J Zeng, et al.
Journal of Medicinal Chemistry|August 30, 1996
Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureasP Y Lam, Y Ru, P K Jadhav, et al.
Journal of Medicinal Chemistry|April 20, 2001
Azepanone-based inhibitors of human and rat cathepsin KR W Marquis, Y Ru, S M LoCastro, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Science (New York, N.Y.)|January 21, 1994
Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitorsP Y Lam, P K Jadhav, C J Eyermann, et al.
The Journal of Biological Chemistry|January 20, 2001
Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitroI E James, R W Marquis, S M Blake, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2001
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primateG B Stroup, M W Lark, D F Veber, et al.
Bone|May 9, 2002
A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized ratMichael W Lark, G B Stroup, I E James, et al.
Journal of Medicinal Chemistry|September 11, 1998
Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin KR W Marquis, D S Yamashita, Y Ru, et al.
Chemistry & Biology|November 18, 1998
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitorsJ D Rodgers, P Y Lam, B L Johnson, et al.
Bioorganic & Medicinal Chemistry|June 3, 1999
Potent dipeptidylketone inhibitors of the cysteine protease cathepsin KR W Marquis, Y Ru, D S Yamashita, et al.
Journal of Medicinal Chemistry|March 23, 2001
Cyclic ketone inhibitors of the cysteine protease cathepsin KR W Marquis, Y Ru, J Zeng, et al.
Journal of Medicinal Chemistry|August 30, 1996
Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureasP Y Lam, Y Ru, P K Jadhav, et al.
Journal of Medicinal Chemistry|April 20, 2001
Azepanone-based inhibitors of human and rat cathepsin KR W Marquis, Y Ru, S M LoCastro, et al.
Pageof 3